Description

4(3H)-Quinazolinone, 8-Methoxy-2-[2-Methoxy-4-[3-[(3S)-3-Methyl-1-Piperidinyl]Propoxy]Phenyl]-3-Methyl- is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound matters for its role as a critical building block in the synthesis of novel, targeted therapeutic agents, offering researchers and manufacturers a reliable and well-characterized starting material. It is primarily needed by pharmaceutical R&D laboratories and fine chemical producers engaged in developing new drug candidates, particularly in oncology and other specialized therapeutic areas.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the research and development of new active pharmaceutical ingredients (APIs).
• Drug Discovery Research: Used in medicinal chemistry for the synthesis and optimization of novel quinazolinone-based drug candidates.
• Oncology Research: Potential building block for compounds targeting specific enzymatic pathways relevant in cancer therapy.
• Chemical Biology: Employed in the synthesis of probes and tool compounds for studying biological mechanisms.
• Process Development: Used in scaling up synthetic routes from laboratory to pilot and commercial production scales.
• Custom Synthesis: A starting point for the contract manufacturing of specialized, non-commercial chemical entities for client-specific projects.

Basic Information

Product Name	4(3H)-Quinazolinone, 8-Methoxy-2-[2-Methoxy-4-[3-[(3S)-3-Methyl-1-Piperidinyl]Propoxy]Phenyl]-3-Methyl-
CAS No.	870996-60-4
Molecular Formula	C26H33N3O4
Molecular Weight	451.56 g/mol
Synonyms	8-Methoxy-2-[2-methoxy-4-[3-[(3S)-3-methyl-1-piperidinyl]propoxy]phenyl]-3-methyl-4(3H)-quinazolinone; (S)-8-Methoxy-2-(2-methoxy-4-(3-(3-methylpiperidin-1-yl)propoxy)phenyl)-3-methylquinazolin-4(3H)-one; 870996-60-4; UNII-9Q6W0I6Z8I; 9Q6W0I6Z8I; 4(3H)-Quinazolinone, 8-methoxy-2-[2-methoxy-4-[3-[(3S)-3-methyl-1-piperidinyl]propoxy]phenyl]-3-methyl-; A selective pharmaceutical intermediate.
EINECS	Contact for details

Quality Control

Our 4(3H)-Quinazolinone derivative is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and spectroscopic identification (NMR, IR, MS), to ensure it meets exacting standards for pharmaceutical research. Certificates of Analysis (COA) with detailed chromatographic data are provided to guarantee traceability, consistency, and compliance with your project requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container sealed to protect this light-sensitive material from moisture and atmospheric contaminants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Single Maximum Impurity	≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.